We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+36.82%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$557M
AUM Growth
+$2.08M
Cap. Flow
-$113M
Cap. Flow %
-20.29%
Top 10 Hldgs %
16.02%
Holding
223
New
33
Increased
18
Reduced
106
Closed
48

Sector Composition

1 Financials 26.16%
2 Healthcare 18.57%
3 Industrials 14.42%
4 Technology 12.29%
5 Consumer Discretionary 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
101
Casella Waste Systems
CWST
$6.09B
$2.2M 0.39%
22,655
-6,150
-21% -$525K
YETI icon
102
Yeti Holdings
YETI
$3.87B
$2.19M 0.39%
+44,219
New +$1.92M
MZTI
103
The Marzetti Company
MZTI
$2.94B
$2.12M 0.38%
18,606
-4,736
-20% -$569K
ERO icon
104
Ero Copper
ERO
$2.52B
$2.11M 0.38%
78,793
-20,158
-20% -$571K
ANAB icon
105
AnaptysBio
ANAB
$1.72B
$2.09M 0.38%
30,926
-8,529
-22% -$517K
KRMN
106
Karman Holdings
KRMN
$6.12B
$2.07M 0.37%
41,559
+11,368
+38% +$735K
CARG icon
107
CarGurus
CARG
$3.16B
$2.06M 0.37%
60,379
-16,607
-22% -$538K
HQY icon
108
HealthEquity
HQY
$8.17B
$2.04M 0.37%
22,590
-7,914
-26% -$671K
INOD icon
109
Innodata
INOD
$1.99B
$1.96M 0.35%
25,961
-19,382
-43% -$1.42M
KTOS icon
110
Kratos Defense & Security Solutions
KTOS
$8.63B
$1.64M 0.29%
32,912
-8,563
-21% -$518K
TOL icon
111
Toll Brothers
TOL
$14.1B
$1.59M 0.29%
9,658
AVBP icon
112
ArriVent BioPharma
AVBP
$1.55B
$1.53M 0.27%
44,044
-12,044
-21% -$355K
UHS icon
113
Universal Health Services
UHS
$9.15B
$1.45M 0.26%
9,723
BIOA
114
BioAge Labs
BIOA
$1.01B
$1.16M 0.21%
+47,491
New +$858K
VSAT icon
115
Viasat
VSAT
$9.76B
$1.16M 0.21%
+12,927
New +$856K
VSH icon
116
Vishay Intertechnology
VSH
$5.8B
$1.14M 0.2%
+21,200
New +$867K
TRAX
117
First Tracks Biotherapeutics
TRAX
$1.27B
$1.09M 0.2%
+54,316
New +$1.02M
NVTS icon
118
Navitas Semiconductor
NVTS
$2.79B
$1.07M 0.19%
+59,921
New +$1.14M
WGS icon
119
GeneDx Holdings
WGS
$1.88B
$1.07M 0.19%
+15,553
New +$884K
AMLX icon
120
Amylyx Pharmaceuticals
AMLX
$1.97B
$1.04M 0.19%
+57,802
New +$894K
SNDK
121
Sandisk
SNDK
$201B
$864K 0.16%
+380
New +$542K
CRS icon
122
Carpenter Technology
CRS
$27.7B
$747K 0.13%
1,211
-3
-0.2% -$1.41K
JOYY
123
JOYY Inc
JOYY
$3.53B
$743K 0.13%
11,263
EWBC icon
124
East-West Bancorp
EWBC
$18.4B
$705K 0.13%
5,460
-15
-0.3% -$1.84K
MKSI icon
125
MKS Inc
MKSI
$21.9B
$582K 0.1%
1,308
+139
+12% +$43.5K

Similar funds

Moody Aldrich Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Moody Aldrich Partners held 223 positions worth $557M, up 0.37% from $555M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Moody Aldrich Partners withdrew a net $113M in Q2 2026, closing 48 positions and reducing 106 holdings. Its most notable exit was Semtech, an estimated $4.95M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Moody Aldrich Partners opened a new position in Skyworks Solutions worth $6.7M.

  • Moody Aldrich Partners's largest Q2 2026 buy was Skyworks Solutions: 98,792 shares worth $6.7M.
  • Moody Aldrich Partners added most to Ligand Pharmaceuticals in Q2 2026, an estimated $3.18M increase.
  • Moody Aldrich Partners's biggest Q2 2026 reduction was MaxLinear, cutting an estimated $12.6M.
  • Moody Aldrich Partners fully exited Semtech in Q2 2026, selling an estimated $4.95M.
  • Moody Aldrich Partners's ten largest holdings make up 16% of its $557M portfolio in Q2 2026.
  • Moody Aldrich Partners opened 33 new positions and closed 48 in Q2 2026.
  • Moody Aldrich Partners's portfolio value rose 0.37% quarter-over-quarter to $557M.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.